Research

Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042499/

Learn more
Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094865/

Learn more
18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968877/

Learn more
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535747/

Learn more
Severe relapse of anti-NMDA receptor encephalitis 5 years after initial symptom onset February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661405/

Learn more
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531245/

Learn more
Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649545/

Learn more
Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444136/

Learn more
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537134/

Learn more
Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398345/

Learn more